CytomX Therapeutics (CTMX) Return on Assets (ROA)
Market Cap: $56.87M
Avg Volume: 1.81M
Industry: Biotechnology
Sector: Healthcare
CytomX Therapeutics Return on Assets (ROA) Summary
CytomX Therapeutics's ROA indicates the return generated on the company's assets:
- Annual: 26.44%
- Quarterly: 15.66%
- TTM: 26.44%
What is Return on Assets (ROA)?
Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.
Related Metrics
Other important metrics to assess CytomX Therapeutics's profitability include:
- ROE (Return on Equity) - measures the return generated on shareholders' equity:
- Annual: -6988.82%
- Quarterly: -4139.47%
- TTM: -146.84%
- ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
- Annual: 62.20%
- Quarterly: 44.16%
- TTM: 62.20%
- Return on Tangible Assets - measures the return generated on the company's tangible assets:
- Annual: 26.78%
- Quarterly: 15.86%
- TTM: 26.78%
- Profit Margin - shows the percentage of revenue that has turned into profit:
- Annual: 23.08%
- Quarterly: 49.55%
- TTM: 23.08%
These metrics provide insights into CytomX Therapeutics's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROA
26.44%
Quarterly ROA
15.66%
TTM ROA
26.44%
CytomX Therapeutics Historical ROA
Historical ROE
Historical ROIC
Historical Profit Margin
Historical Return on Tangible Assets
CytomX Therapeutics Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | ROA | ROE | ROIC | Profit Margin | Return on Tangible Assets |
|---|---|---|---|---|---|
| 2024 | 26.44% | -6988.82% | 62.20% | 23.08% | 26.78% |
| 2023 | -0.28% | 1.20% | 2.20% | -0.56% | -0.28% |
| 2022 | -37.29% | 113.47% | -88.35% | -183.02% | -37.56% |
| 2021 | -23.76% | -90.23% | -34.14% | -115.92% | -23.90% |
| 2020 | -9.17% | -66.03% | -13.09% | -32.77% | -9.22% |
| 2019 | -29.96% | -200.02% | -42.72% | -177.84% | -30.16% |
| 2018 | -18.51% | -64.64% | -26.09% | -142.19% | -18.61% |
| 2017 | -10.84% | -61.66% | -13.59% | -60.17% | -10.91% |
| 2016 | -29.58% | -75.05% | -36.46% | -391.54% | -29.99% |
| 2015 | -17.94% | -28.06% | -18.30% | -458.69% | -18.19% |
Related Metrics
Explore detailed financial metrics and analysis for CTMX.